Figure 5.Combined value of HOXC6 and serum AFP identify different risks of HCC death and recurrence. The associations of HOXC6/AFP co-expression with Overall survival (log-rank P < 0.001) (A) and Time to recurrence (log-rank P < 0.001) (B) in 164 HCC patients.
